hsa-mir-513b: Hsa-mir-513b is a microRNA that has been implicated in various biological processes and diseases [PMC8241782]. In a study, it was found that hsa-mir-513b, along with other miRNAs, may play a key role in regulating hub-genes in certain pathways [PMC8241782]. Another research identified hsa-mir-513b as one of the miRNAs that may be involved in regulating hub-genes and its high levels were associated with worse disease-free survival [PMC8241782]. Hsa-mir-513b was also found to potentially regulate the expression of CXCL8, along with other miRNAs [PMC8241782]. Additionally, hsa-mir-513b was found to have a potential regulatory effect on CXCL1 [PMC8241782]. Elevated levels of hsa-mir-513b were associated with worse disease-free survival [PMC8241782]. In the context of different diseases, hsa-mir-513b has been identified as one of the highly accurate miRNAs for diagnosing patients with nasopharyngeal carcinoma and intrahepatic cholangiocarcinoma [PMC9318750][PMC7257878]. Furthermore, hsa-mir-513b has been implicated in polycystic ovary syndrome and lung cancer [PMC4508762][PMC4826230]. In patients with membranous nephropathy, downregulation of hsa-mir-513b was observed [PMC8610666]. Overall, these studies highlight the potential role of hsa-mir-513b in various biological processes and diseases.